Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Methapharm is a privately held specialty pharmaceutical company focused on the development, manufacturing, and distribution of diagnostic and therapeutic products. The company is best known for its respiratory diagnostic products, particularly Provocholine (methacholine chloride), which is the gold standard for bronchial challenge testing to aid in the diagnosis of asthma. Methapharm operates across North America and Europe, providing specialized solutions for hospital and clinical settings. In addition to its proprietary respiratory line, the company manages a portfolio of specialty generic and branded products through its distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Methap.